RESUMO
OBJECTIVE: Analysis of gestational hypercholesterolemia incidence in Prague population of healthy pregnant women. Diagnostic significance of non-cholesterol sterols as suitable markers of endogenous synthesis and intestinal absorption in etiology of gestational hypercholesterolemia. DESIGN: Retrospective study. PATIENTS AND METHODS: From 21 000 healthy pregnant women set of 84 patients with blood level of total cholesterol >7.0 mmol/l where noncholesterol sterols had been analyzed by use of GC/MS method on Finnigan MAT 120b. Lathosterol and desmosterol as markers of endogenous syntesis and campesterol and sitosterol as markers for intestinal absorbtion. Classical lipid parameters have been analyzed on Beckman Coulter and Cobas analyzators. RESULTS: The median of total cholesterol values in the set of 21 000 healthy pregnant women - 6,8 mmol/l was observed; median of LDLCh - 4.6 mmol/l and HDLCh - 2.2 mmol/l. The frequency of hypercholesterolemia values > 8.0 mmol/l 1:132 (!) was observed. The average values were for lathosterol 7.8 ± 1.7 µmol/l; desmosterol 4.7 ± 0.9 µmol/l; campesterol 9.8 ± 2.6 µmol/l; sitosterol 9.6 ± 3.8 µmol/l. The correlations of lathosterol with total cholesterol r = 0.524 as well as with non-HDLCh r = 0.35 and LDLCh r = 0.36 were observed. In campesterol or sitosterol as well as HDLCh or TAG no significant correlations have been observed. DISCUSSION: Pilot study for gestational hypercholesterolemias in Czech population of healthy pregnant women proved the high frequency of increased levels of total cholesterol (> 8.0 mmol/l) 1:132. Increased levels of lathosterol values could explain the hypercholesterolemia in pregnancy as result of higher endogene synthesis of cholesterol. CONCLUSION: Relatively high frequency of hypercholesterolemia in pregnancy is caused according to our findings by increased endogenous synthesis of cholesterol via lathosterol. The highly increased values of cholesterolemia during pregnancy could be efectivelly used for detection and after ending of lactation period for further differential diagnostic and treatment of previously undiagnosed familial hypercholesterolemias.
Assuntos
Hipercolesterolemia/sangue , Hipercolesterolemia/etiologia , Esteróis/sangue , República Tcheca/epidemiologia , Feminino , Humanos , Hipercolesterolemia/epidemiologia , Hiperlipidemias , Incidência , Projetos Piloto , Gravidez , Estudos RetrospectivosRESUMO
Homocystein (Hcy) is regarded as a neuroexcitatory substance, which is therefore used as an epileptogenic agent in experimental epileptology. Experiments "in vivo" as well as "in vitro" revealed its relation to NMDA glutamate receptors, and its potential neurotoxicity. From the clinical aspect, hyperhomocysteinemia (HHcy), mostly as a marker of the risk factor in the vascular damage, was often studied in patients treated with antiepileptic drugs (AE). However, the neuroexcitatory influence of mild HHcy (up to 30 micromol/l) was rarely discussed. Out of a group of 123 adult patients on long-term conventional AE we analyzed 8 patients (7 men and one woman) with moderate to severe HHcy (30.7-109.0 micromol/l) retrospectively and 2-5 years after HHcy normalization. All of them suffered from partial and/or secondary generalized seizures accompanied by neuropsychological impairment depending on the aetiology of the disease. The patients were characterized by a concurrence of several factors: (1) All of them received conventional AEs inducing the cytochrome P 450 at the time HHcy was diagnosed. (2) Molecular-genetic tests showed enzymopathic impairment (methylentetrahydrofolate reductase-MTHFR mutation of the gene C677 T) also in all eight, homozygous in 7 cases and heterozygous in 1 case. (3) All patients were found to have a vitamin deficit or marginal values of at least one of the vitamins under study, especially folate and/or vitamin B6 and 812. With reference to clinical and EEG features, the potential neuroexcitatory influence of Hcy is discussed taking into account its effect on pathogenetic factors.
Assuntos
Anticonvulsivantes/efeitos adversos , Epilepsia/tratamento farmacológico , Hiper-Homocisteinemia/induzido quimicamente , Adulto , Idoso , Eletroencefalografia , Epilepsia/fisiopatologia , Feminino , Humanos , Hiper-Homocisteinemia/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Vitaminas/uso terapêuticoRESUMO
Although several genetic factors have been implicated as determinants of blood folate concentration in various populations, their effect on folate status in the Czech population has not yet been examined. We explored whether blood folate concentrations in healthy Czech population are associated with polymorphisms in 5,10-methylenetetrahydrofolate reductase (MTHFR), folate hydrolase 1 (FOLH1), reduced folate carrier (RFC), and folate receptor (FOLR1) genes. In a cross-sectional study of 591 control subjects we determined genotypes by PCR-RFLP or ARMS-PCR methods, and plasma and erythrocyte folates by MEIA. The effect of different genotypes on folate status was examined by non-parametric tests and by regression analysis. The prevalence of the MTHFR 677C>T, MTHFR 1298A>C, FOLH1 1561C>T, RFC 80G>A and FOLR1 480G>C variant alleles was 0.34, 0.33, 0.05, 0.44 and 0.00, respectively. Only the MTHFR 677C>T variant was significantly associated with plasma folate concentrations (median 14.7, 14.0 and 12.2 nmol/l for the CC, CT and TT genotypes, respectively). Our study showed that among the five studied allelic variants, only the 677C>T polymorphism in the MTHFR gene is a significant genetic determinant of plasma folate concentrations in Czech population.
Assuntos
Hidrocarboneto de Aril Hidroxilases/genética , Ácido Fólico/administração & dosagem , Ácido Fólico/sangue , Neoplasias Pulmonares/enzimologia , Neoplasias Pulmonares/epidemiologia , Metilenotetra-Hidrofolato Desidrogenase (NAD+)/sangue , Metilenotetra-Hidrofolato Desidrogenase (NAD+)/genética , Medição de Risco/métodos , República Tcheca/epidemiologia , Análise Mutacional de DNA/métodos , Suplementos Nutricionais , Feminino , Predisposição Genética para Doença/epidemiologia , Testes Genéticos/métodos , Humanos , Neoplasias Pulmonares/genética , Masculino , Pessoa de Meia-Idade , Polimorfismo Genético , Fatores de RiscoRESUMO
Two patients with a suspected peroxisomal disorder on the basis of neurological, craniofacial, hepatological and other abnormalities were studied. The phenotype of both girls was remarkably similar from birth until age 1.5 yr. Detailed studies in plasma revealed normal plasma very-long-chain fatty acids but the presence of di- and trihydroxycholestanoic acids and the C29-dicarboxylic bile acid, all known to occur in plasma from Zellweger patients. These results suggest an isolated defect in the peroxisomal beta-oxidation of the side chains of the cholestanoic acids. Activation of trihydroxycholestanoic acid and beta-oxidation of trihydroxycholestanoyl-CoA, measured in a liver biopsy, were normal, however, as was the peroxisomal beta-oxidation of palmitate. Although the molecular defect remains unknown, the results stress the importance of performing multiple analyses in any patient suspected to suffer from a peroxisomal disorder and indicate that screening for peroxisomal disorders based upon analysis of only plasma very long chain fatty acids with or without analysis of erythrocyte plasmalogen levels, may be inadequate.
Assuntos
Anormalidades Múltiplas/metabolismo , Colestanóis/metabolismo , Doenças em Gêmeos , Proteínas Repressoras , Proteínas de Saccharomyces cerevisiae , Anormalidades Múltiplas/sangue , Anormalidades Múltiplas/patologia , Acil Coenzima A/metabolismo , Ácidos e Sais Biliares/metabolismo , Células Cultivadas , Coenzima A Ligases/metabolismo , Ácidos Dicarboxílicos/metabolismo , Ácidos Graxos não Esterificados/sangue , Ácidos Graxos não Esterificados/metabolismo , Feminino , Fibroblastos/metabolismo , Humanos , Lactente , Fígado/metabolismo , Fígado/patologia , Fígado/ultraestrutura , Microcorpos/metabolismo , Microcorpos/ultraestrutura , Palmitoil Coenzima A/metabolismo , Fenótipo , Pele/metabolismo , Gêmeos Dizigóticos , Síndrome de Zellweger/metabolismoRESUMO
A stable isotope dilution assay using D3-mevalonic acid was developed and applied to the study of mevalonic aciduria. The method also appears to be suitable for the evaluation of different therapeutic regimens in patients with hypercholesterolemia. Mevalonic acid was isolated by liquid partition chromatography and quantified as the underivatized lactone by means of ammonia chemical ionization selected ion monitoring capillary gas chromatography-mass spectrometry. In heterozygotes there was significantly greater urinary excretion of mevalonic acid, while the range of enzymatic activity of mevalonate kinase showed an overlap with that of controls. The analysis of amniotic fluids of two pregnancies at risk for mevalonic aciduria showed a 3277-fold elevation as compared to controls in the first case, diagnostic of an affected fetus, and a normal value in the second one. Mevalonic acid concentration was much increased in tissues of the affected and aborted fetus. Concentrations ranged from 840 to 1120 mumol/kg in various tissues and were as high as 1810 mumol/kg in brain. Concentrations in control fetal tissues were approximately 1 mumol/kg.
Assuntos
Doenças Fetais/diagnóstico , Heterozigoto , Ácido Mevalônico/urina , Fosfotransferases (Aceptor do Grupo Álcool) , Diagnóstico Pré-Natal , Adulto , Líquido Amniótico/química , Linhagem Celular , Criança , Colesterol/biossíntese , Feminino , Feto/química , Cromatografia Gasosa-Espectrometria de Massas/métodos , Humanos , Técnicas de Diluição do Indicador , Lactente , Recém-Nascido , Masculino , Ácido Mevalônico/análise , Ácido Mevalônico/sangue , Ácido Mevalônico/metabolismo , Fosfotransferases/metabolismo , Gravidez , Sensibilidade e EspecificidadeRESUMO
OBJECTIVE: Characteristics of sexual life in women with hyperphenylalaninemia. DESIGN: Anamnestic study. SETTING: Department of Obstetrics and Gynaecology and Institute of Inherited Metabolic Disorders of General Faculty Hospital and 1st Medical Faculty of Charles University in Prague, Department of Clinical Biochemistry, Haemathology and Immunology of Hospital Na Homolce in Prague. METHODS: Characteristics of sexual life were studied in a group of 16 women with hyperphenylalaninemia. RESULTS: One fourth of the women lives without sex. In the rest of them sexual function is normal. CONCLUSION: One fourth of the women stays out of reproduction.
Assuntos
Fenilcetonúrias , Comportamento Sexual , Adolescente , Adulto , Coito , Feminino , HumanosRESUMO
OBJECTIVE: Anthropometric investigation in women with hyperphenylalaninemia. DESIGN: Retrospective clinical study. SETTING: Department of Obstetrics and Gynecology and Institute of Inherited Metabolic Disorders of General Faculty Hospital and 1st Medical Faculty of Charles University in Prague, Department of clinical Biochemistry, Hematology and Immunology of Hospital Na Homolce in Prague. METHODS: 44 anthropometric and 12 anthroposcopic parameters were studied in a group of 16 women with reproduction normality. RESULTS: Smaller body heights, pathological body posture and dysplastic findings were found. CONCLUSION: Registered differences and dysplastic findings are motivating for studies in a larger group of women with hyperphenylalaninemia.
Assuntos
Antropometria , Fenilcetonúrias/patologia , Adulto , Feminino , Humanos , Fenilcetonúrias/diagnóstico , Fenilcetonúrias/dietoterapia , Estudos RetrospectivosRESUMO
OBJECTIVE: Metabolic study on plasmatic levels of homocysteine (Hcy) in 30 women post ovarectomy suffering from benign diseases. Based on previous pilot study by 6 women patients after ovarectomy the Hcy level increase has been supposed. Further objective was to detect possible change of homocysteinemia after application of estrogen replacement therapy (ERT). Hyperhomocysteinemia (HHC)--increased level of free amino acid homocysteine in blood--is considered on lipids independent risk factor in early development of cardiovascular diseases. The deficiency of 5,10-methylatetetrahydrofolate reductase (mutation C677T) is suspected as the main reason for decreased remethylation of Hcy. The group of women heterozygous for MTHFR mutation was compared with group of women patients without this mutation during the 8 weeks--monitoring after application of foliculostimulating hormone (FSH), estradiol (E2) for folate, vitamin B12 and Hcy in plasma. DESIGN: Basic study to get our own data about HHC in population of operated women before and after ovarectomy and after ERT. SETTING: Department of Obstetrics and Gynaecology, 1st Faculty of Medicine, Charles University, Prague. METHODS: Total homocysteine in plasma was estimated by chromatographic method with use of fluorescence detection. The level of hormones in plasma was estimated by RIA test of DCL company. The mutation of gen for 5,10-MTHFR was estimated by genetic examination. Six blood taking were performed within 8 weeks. The 1st before ovarectomy, further 1., 3., 7., 28. and 56. day after operation. Since the 28th day 50 micrograms of 17-beta estradiol have been substituted by weekly transdermal system. RESULTS: No homozygote for 5,10-MTHFR has been found in the group of operated women, only 5 heterozygotes and 25 healthy homozygotes were found. Hcy values were similar in both groups. The patients were distributed into 2 groups according to their FSM level in the plasma (40 UI/I was stipulated as the limit). After ovarectomy the Hcy increased by both groups and after hormonal treatment the Hcy decreased. The folate level in both groups corresponded with Hcy level, in B12 vitamin concentration no dependence has been proved (P < 0.0001). CONCLUSION: Significant increase of Hcy levels after overactomy and subsequent decrease after substitutive treatment by estradiol. This correlation was followed by folate levels. No difference or correlation in monitored parameters was observed between heterozygotes for MTHFR and healthy homozygotes.
Assuntos
Homocisteína/sangue , Ovariectomia , Estradiol/sangue , Terapia de Reposição de Estrogênios , Feminino , Hormônio Foliculoestimulante/sangue , Humanos , Metilenotetra-Hidrofolato Redutase (NADPH2) , Pessoa de Meia-Idade , Mutação , Oxirredutases atuantes sobre Doadores de Grupo CH-NH/genéticaRESUMO
OBJECTIVE: Metabolic study on plasmatic levels of homocysteine (Hcy) in healthy women during normal or pathological pregnancy accompanied with corresponding levels of Hcy in amniotic fluid and foetal sera. Increased levels of Hcy--hyperhomocysteinaemia is respected as an independent risk factor accelerating the early development of vessel damage and causing the neural tube defects (NTD). DESIGN: Basic study to get our own data about Hcy in Czech healthy and population at risk of pregnant and non-pregnant women. SETTING: Department of Obstetrics and Gynaecology, 1st Faculty of Medicine, Charles University, Prague. METHODS: Total homocysteine in plasma, amniotic fluid and foetal sera was estimated by chromatographic method with use of fluorescence detection. RESULTS: Normal homocysteine in preclimacteric healthy nonpregnant women is: 9.7 +/- 1.6 mumol/l with evident age-dependence. In healthy climacteric women are higher levels of Hcy (corresponding to the men values): 11.8 +/- 2.6 mumol/l. After use of hormonal contraceptives the plasmatic levels of Hcy decrease: 7.2 +/- 2.0 mumol/l. In physiological pregnancies Hcy reachs the lowest values: 4.4 +/- 1.7 mumol/l with any evident oscillations during pregnancy. In women in childbed period was Hcy 8.4 +/- 2.1 mumol/l observed. In pathological pregnanciesare its levels slightly elevated: 6.3 +/- 2.1 mumol/l, most evident in placental abruptions: 7.5 +/- 1.7 mumol/l. In pregnant women with susp. results of screening on M. Down only unsignificant increase of Hcy was observed: 6.12 +/- 2.4 mumol/l. In amnial fluids of healthy pregnant women are levels of Hcy are quite low: 4.1 +/- 1.2 mumol/l with any oscillations during pregnancy. In foetal sera of pregnancies at risk (NTD, susp., trisomy, inborn errors of metabolism): 3.6 +/- 1.4 mumol/l of Hcy was detected. The foetoplacental quotient for Hcy is 0.62. CONCLUSION: Average values for Hcy were established in physiological as well as in pathological pregnancies and till now only limited diagnostic significance has been observed. The hyperhomocysteinaemia mentioned in previous papers was not in NTD observed because our pregnant patients were regularly supplemented with all critical vitamins (folate, B6, B12).
Assuntos
Homocisteína/sangue , Complicações na Gravidez/sangue , Adolescente , Adulto , Idoso , Criança , Climatério/sangue , Anormalidades Congênitas/sangue , Feminino , Homocisteína/análise , Humanos , Pessoa de Meia-Idade , Período Pós-Parto/sangue , Gravidez , Fatores de RiscoRESUMO
In the paper we show results of medical study from statistical point of view. The medical study was aimed to study genetic risk factors of peripheral arterial occlusive diseases in Czech population. Two genes, CBS and MTHFR were examined, as various genotypes of these genes are thought to have impact on amino thiols, who participate in variety of reactions in vasculature. Statistical part of the study was responsible for analysis and interpretation of collected data.
Assuntos
Arteriopatias Oclusivas/genética , Coleta de Dados , Predisposição Genética para Doença/genética , Computação Matemática , Adulto , Idoso , Idoso de 80 Anos ou mais , Aminoácidos Sulfúricos/genética , Cistationina beta-Sintase/genética , Feminino , Genótipo , Humanos , Masculino , Metilenotetra-Hidrofolato Redutase (NADPH2) , Pessoa de Meia-Idade , Modelos Genéticos , Oxirredutases atuantes sobre Doadores de Grupo CH-NH/genética , Medição de RiscoRESUMO
INTRODUCTION: The increased level of phenylalanine (Phe) in maternal blood--hyperphenylalaninemia (mHPA) has a detrimental effect on the early development of healthy foetus (1965). The toxic effect causes spontaneous abortion or retards intrauterine growth, skeletal malformation, cardiac anomalies can appear. However the most frequent are microcephaly, mental retardation and hypotrophy. PATIENTS AND METHODS: Simultaneously with the introduction of obligatory "Newborn Screening Program" in CR also the facultative screening for mHPA was introduced ("Maternal Hyperphenylalaninemia Preventive Screening Program"). Since 1975 till now 222,990 healthy pregnant women (16-47 yrs) from city Prague and its area (cca 2 mil. inh.) have been screened for increased Phe in blood by Efron's chromatographic screening test (1964); Phe cut off value: 240 micromol/l. Nonfasting venous blood has been taken in 2nd-3rd month of pregnancy during the first antenatal visit. All positive cases have been verified with quantitative Phe estimation on amino acid analyzer incl. pterines analysis in urine. For differentiation of detected mHPAs the Güttler's scheme (1980) has been used. Mutations for Phe-hydroxylase gene analyzed by restriction enzyme digestion after Guldberg (1994). RESULTS: The average incidence of mHPA detected at the beginning of pregnancy was found 1:8675. The major part (65.3%) of all detected mHPA belongs to mild or moderate form of phenylketonuria (PKU) with most frequent PAH gene mutations R408W, Y414C, IVS11 nt8g-a, R158Q, IVS12ntlg-a and R261Q. 19.2% corresponds to atypical or classical PKU with prevailing mutation R408W. Only in 15.3% were detected non-PKU (persistent HPA) with mutations R408W, Y414C, IVS12ntlg-a, IV11nt8g-a and A403V. 28 offsprings born from pregnancies on low-phenylalanine diet (LPD) introduced at least 2 months before the conception and during the whole pregnancy show normal psychomotoric development. In 7 offsprings without LPD or after delayed introducing or on PLD or badly monitored showed malformations (microcephaly, hypotrophy, skeletal malformations) or died. DISCUSSION: Relatively high incidence of mHPA detected in healthy population of pregnant women of Prague area differs from findings of Buist (1989) or Levy (1994) from American pregnant women screened for mHPA from umbilical blood. We consider that screening performed at the beginning of pregnancy from nonfasting venous blood is more effective compared to umbilical blood from two reasons: the Phe level in maternal blood is increased during first trimester of pregnancy due to succing effect of placenta in comparison to decreased Phe level at the end of labour. Umbilical blood for screening of mHPA is not quite suitable to detect the atypical or mild forms of Phe disturbances which prevailed in our Slavonic population of pregnant women. (Tab. 5, Fig. 7, Ref. 16.)
Assuntos
Fenilcetonúrias/diagnóstico , Complicações na Gravidez/diagnóstico , Adolescente , Adulto , República Tcheca , Feminino , Humanos , Incidência , Programas de Rastreamento , Pessoa de Meia-Idade , Fenilcetonúrias/epidemiologia , Fenilcetonúrias/terapia , Gravidez , Complicações na Gravidez/epidemiologia , Complicações na Gravidez/terapiaRESUMO
BACKGROUND: Homocystinuria due to cystathionine beta-synthase deficiency is an autosomal recessive disorder of methionine metabolism. It manifests with vascular, central nervous system and connective tissue disturbances, and phenotypically resembles Marfan's syndrome. We analysed the clinical course of homocystinuria in Czech and Slovak patients. METHODS AND RESULTS: The group of homocystinuric patients consisted of 19 individuals (12 males and 7 females) aged 5-32 years (average age 18 years), who were diagnosed between 1980 and 1999. The overall incidence of homocystinuria in the Czech and Slovak Republics was 1:287,000. The proportion of pyridoxine-responsive patients was 47%. The average follow-up period was 10 years (range 1 month to 19 years). The prevalence of the individual signs in the group was as follows: lens dislocation--95% of patients, progressive myopia--79%, marfanoid habitus--74%, kyfoscoliosis--68%, osteoporosis--63%, psychomotor retardation--58%, other neurologic symptomatology--58% and tromboembolism--21%. The average delay between the first sign of the disease and the time when the diagnosis was made was 4 years (range 1 to 14 years). At the time of diagnosis the average levels of metabolites in plasma were as follows: total homocysteine 348 mumol/l (range 211-536), free homocystine 70 mumol/l (range 0-203) and methionine 359 mumol/l (range 75-937). CONCLUSIONS: Both the clinical course of homocystinuria due to the cystathionine beta-synthase deficiency and its incidence in the Czech and Slovak Republics are similar to those in other populations. Since homocystinuria is a treatable disease, it should be included in the differential diagnosis of Marfan's syndrome, tromboembolism and severe psychomotor retardation.
Assuntos
Homocistinúria/complicações , Adolescente , Adulto , Criança , Pré-Escolar , República Tcheca/epidemiologia , Feminino , Homocistinúria/diagnóstico , Homocistinúria/epidemiologia , Humanos , Incidência , Masculino , Eslováquia/epidemiologiaRESUMO
BACKGROUND: Elevated phenylalanine levels in maternal blood (hyperphenylalaninaemia) during pregnancy damages the developing foetal tissues. Early detection of pregnant women with hyperphenylalaninaemia and adherence to a low phenylalanine diet already before conception and throughout pregnancy can prevent this damage. The objective of the investigation are results achieved screening and strict monitoring of low phenylalanine dietetic treatment in detected pregnant women of the Prague population. METHODS AND RESULTS: 186 350 healthy women of the Prague population were examined by the chromatographic screening test in a venous blood sample during their first visit in a maternity welfare centre and 22 positive cases were detected (incidence 1:8470). In 86% mild, persistent or benign forms of phenylketonuria were involved. Nineteen patients were treated by a low phenylalanine diet and the phenylalanine tolerance was monitored as well as the nitrogen balance, amino acids in serum and urine, protein markers, trace elements, vitamins, lipids, the body mass index-BMI, changes of body weight after introduction of the dietetic treatment and treatment during pregnancy. A significant increase of the phenylalanine tolerance by 20 to 200% was found, mostly in the second half of pregnancy and reduced values of serum and urinary selenium. The decrease of body weight when the diet was introduced and the increment during pregnancy correlated with the BMI value. In the other investigated parameters no significant deviations were found. CONCLUSION: Fifteen healthy children with normal psychomotor development delivered by 12 mothers with hyperphenylalaninaemia provide evidence of the effectiveness of prenatal screening for hyperphenylalaninaemia during pregnancy.
Assuntos
Fenilalanina/sangue , Fenilcetonúria Materna/epidemiologia , Complicações na Gravidez/diagnóstico , Adolescente , Adulto , República Tcheca/epidemiologia , Feminino , Humanos , Incidência , Recém-Nascido , Programas de Rastreamento , Fenilcetonúria Materna/diagnóstico , Fenilcetonúria Materna/dietoterapia , Fenilcetonúrias/prevenção & controle , Gravidez , Complicações na Gravidez/dietoterapia , Complicações na Gravidez/epidemiologiaRESUMO
Lysosomal lipase deficiency is a hereditary autosomal recessive enzymopathy leading to lysosomal storage of triacylglycerols (TAG) and cholesterol esters (CE). In particular cells with a permanently high receptor-mediated LDL endocytosis are affected (liver, kidneys). There are two basic phenotypes. The fatal infantile phenotype (Wolman's disease) with generalized storage of both types of apolar lipids. This form was diagnosed in this country only once. The opposite is the protracted, oligosymptomatic form encountered in all age groups. It is characterized by the storage of CE (which gave this entity the name of cholesteryl storage disease--CESD). Its main sign is affection of the liver (hepatomegaly, hepatopathy), which in some instances may lead to organ failure, directly or after cirrhotic transformation. Furthermore there is permanent hypercholesterolaemia (high LDL cholesterol) due to increased VLDL synthesis by hepatocytes, low HDL cholesterol and variably raised TAG. This constellation of blood lipids is a risk factor for the development of atherosclerosis. In the course of 25 years in the Czech Republic 13 cases of CESD were diagnosed in 11 families. Ten of these cases were characterized by clinically manifest hepatopathy with hepatomegaly, detected incidentally during medical examinations (at the age of 2-14 years). In three adult patients with permanent hypercholesterolaemia the storage process was subclinical and the diagnosis was established quite incidentally by examination of non-specific secondary and tertiary manifestations of the disease. The diagnosis was established in all cases of CESD at the tissue level (liver biopsy), at the biochemical (acid lipase deficiency) and molecular genetic level (mutation in enzyme locus). In all instances mutation of G934A was found leading to reduction and loss of the eighth exon. This mutation was present in five patients in a homozygous state. Six mutations were heterozygous. In one instance for technical reasons only one allele was analyzed. In three instances a point "missense" mutation was found: T323A (Trp74Arg), T4(75)A (Asp124Glu), A210T (Asp36Gl), in one instance a "nonsense" mutation: C233T (Arg44-stop) and twice a deletion mutation delta C673-5 and delta G1068-8 leading to impairment of the reading frame and to premature stop of the codon.
Assuntos
Doença do Armazenamento de Colesterol Éster , Lipase/deficiência , Lisossomos/enzimologia , Doença de Wolman , Adulto , Doença do Armazenamento de Colesterol Éster/diagnóstico , Doença do Armazenamento de Colesterol Éster/epidemiologia , República Tcheca/epidemiologia , Feminino , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Doença de Wolman/diagnóstico , Doença de Wolman/epidemiologiaRESUMO
BACKGROUND: A rise of the homocysteine plasma level--mild hyperhomocysteinaemia--is considered an independent risk factor for the development of vascular damage. It is due to hereditary deficiency of 5,10-methylene-tetrahydrofolate reductase with accentuation of vitamin deficiency (folic acid, vitamin B6 and B12). In previous studies the authors confirmed this fact in the population of patients with aortocoronary or peripheral arterial bypasses. The assumed autosomal recessive transmission of this deficiency should make it possible to detect carriers of this metabolic deviation already in childhood. By selective screening of the child population at risk it would thus be possible to detect affected subjects in time and prevent the development of vascular disease by preventive folate administration. METHODS AND RESULTS: In a group of 38 children and grandchildren from risk families where at least one of the parents or grandparents was operated on account of vascular obliterating disease the total homocysteine plasma level was examined by the chromatographic method. An increase of total homocystein (8.7 +/- 2.7 mumol/l) was found as compared with children from the non-risk population (5.4 +/- 1.8 mumol/l), (p < 0.001). The total homocysteine values however were dependent on the child's age and were more marked in children above 12 years of age. In the parental population mild hyperhomocysteinaemia was present in 38% of those with aortocoronary bypasses and in 43% of those with peripheral arterial bypasses. CONCLUSIONS: The authors found significantly elevated total homocysteine levels in the child population from risk families with obliterating vascular disease. The total homocysteine level depends on the child's age and is more markedly expressed in children above 12 years of age.
Assuntos
Doença das Coronárias/genética , Hiper-Homocisteinemia/genética , Doenças Vasculares Periféricas/genética , Adolescente , Adulto , Idoso , Criança , Pré-Escolar , Doença das Coronárias/complicações , Humanos , Hiper-Homocisteinemia/complicações , Pessoa de Meia-Idade , Doenças Vasculares Periféricas/complicações , Fatores de RiscoRESUMO
The lecture submits a survey of the most frequent primary congenital disorders of amino acid metabolism and discusses their diagnostic significance for clinical biochemistry, paediatrics and antenatal medicine. The results of multiple chromatographic screening of these diseases, which has been carried out systematically since 1961, are commented on. It was demonstrated that all congenital disorders of amino acid metabolism can be found in the Czechoslovak population, provided that they are systematically diagnosed. The incidence of individual diseases in series of healthy and mentally retarded children belonging to different age groups is shown in the relevant tables.
Assuntos
Erros Inatos do Metabolismo dos Aminoácidos/diagnóstico , Ensaios Enzimáticos Clínicos , Programas de Rastreamento , Humanos , Recém-NascidoRESUMO
In a systematic examination of children from incestuous unions by screening tests for congenital disorders of amino acid metabolism, we found an infant with raised urinary excretion of cystathionine, cystine derivatives and isulphides and serious psychomotor retardation. The serum cystathionine and disulphide level was found to be elevated. A tolerance test with methionine and vitamin B12 and tests of other metabolites in the blood and urine confirmed the diagnosis of primary cystathioninuria, the first recorded case in the Czechoslovak population. A differential diagnosis against all the other known congenital metabolic disorders involving the sulphurated amino acids was carried out.
Assuntos
Erros Inatos do Metabolismo dos Aminoácidos/genética , Cistationina/metabolismo , Criança , Cistationina gama-Liase/deficiência , Feminino , Humanos , Incesto , Masculino , LinhagemRESUMO
Screening tests of tyrosine levels in the newborn population showed that an elevated blood tyrosine level is the second commonest, and diagnostically the most serious, problem of neonatal age. Almost 1% of all newborn infants have a raised tyrosine level. The classic form of tyrosinosis and secondary hypertyrosinaemia in particular must be differentiated from benign, transitory forms. Methods for a differential diagnosis after loading the organism with ascorbic acid, pyridoxine or folic acid have been described. L-tyrosine tolerance tests proved ineffective. The results of the dietary treatment of transitory and classic forms of hypertyrosinaemia, using phenylalanine- and tyrosine-free hydrolysates, are described. The incidence of these diseases at different ages is shown in a table. Study of psychomotric development shows that untreated children do not display a subnormal IQ until they are of pre-school or school age.
Assuntos
Erros Inatos do Metabolismo dos Aminoácidos/diagnóstico , Tirosina/metabolismo , Erros Inatos do Metabolismo dos Aminoácidos/genética , Criança , Diagnóstico Diferencial , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Programas de Rastreamento , FenilalaninaRESUMO
The EEG of 10 phenylketonuric children treated by a diet and of 4 children with hyperphenylalaninaemia on a normal diet was recorded during L-phenylalanine tolerance tests. The first recording was made before administering the L-phenylalanine load (100 mg/kg b.w.) and the second 60-120 min after. In 6 of the phenylketonuric children, nonspecific abnormality became more pronounced or increased, or previously absent epileptic graphoelements appeared. A pathological EEG response to a L-phenylalanine load was found in 1 child with hyperphenylalaninaemia. The authors do not recommend relaxation of the diet in children with a pathological EEG response to a L-phenylalanine load.
Assuntos
Fenilalanina , Fenilcetonúrias/diagnóstico , Adulto , Criança , Diagnóstico Diferencial , Eletroencefalografia , Heterozigoto , Humanos , Fenilcetonúrias/genéticaRESUMO
The report discusses the first results obtained by chromatographic screening of the blood amino acids in pregnant women at the outset of pregnancy. Typical cases of maternal phenylketonuria and maternal hyperphenylalaninaemia found among 2,000 women examined are described in detail, giving a concise metabolic, clinical and genetic picture. The biochemical possibilities of diagnosing congenital disorders of amino acid metabolism before birth are also discussed.